2020 ESPGHAN意见书:单基因型炎症性肠病的临床基因组学诊断

2020-12-16 欧洲儿科胃肠病学、肝病学和营养协会 J Pediatr Gastroenterol Nutr . 2020 Dec 16;

2020年12月,欧洲儿科胃肠病学、肝病学和营养协会(ESPGHAN)儿童IBD波尔图小组发布了关于单基因型炎症性肠病的临床基因组学诊断意见书。单基因型炎症性肠病的鉴别很重要,因其治疗不同于传统类型I

中文标题:

2020 ESPGHAN意见书:单基因型炎症性肠病的临床基因组学诊断

英文标题:

Clinical Genomics for the Diagnosis of Monogenic forms of Inflammatory Bowel Disease: A Position Paper from The Paediatric IBD Porto Group of ESPGHAN

发布日期:

2020-12-16

简要介绍:

2020年12月,欧洲儿科胃肠病学、肝病学和营养协会(ESPGHAN)儿童IBD波尔图小组发布了关于单基因型炎症性肠病的临床基因组学诊断意见书。单基因型炎症性肠病的鉴别很重要,因其治疗不同于传统类型IBD。本文主要针对单基因型炎症性肠病的临床基因组学诊断的相关内容提供声明建议。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2020 ESPGHAN意见书:单基因型炎症性肠病的临床基因组学诊.pdf)] GetToolGuiderByIdResponse(projectId=1, id=efa0b1c0020321c8, title=2020 ESPGHAN意见书:单基因型炎症性肠病的临床基因组学诊断, enTitle=Clinical Genomics for the Diagnosis of Monogenic forms of Inflammatory Bowel Disease: A Position Paper from The Paediatric IBD Porto Group of ESPGHAN, guiderFrom=J Pediatr Gastroenterol Nutr . 2020 Dec 16;, authorId=0, author=, summary=2020年12月,欧洲儿科胃肠病学、肝病学和营养协会(ESPGHAN)儿童IBD波尔图小组发布了关于单基因型炎症性肠病的临床基因组学诊断意见书。单基因型炎症性肠病的鉴别很重要,因其治疗不同于传统类型I, cover=https://img.medsci.cn/20201230/1609258572779_2020535.jpg, journalId=0, articlesId=null, associationId=515, associationName=欧洲儿科胃肠病学、肝病学和营养协会, associationIntro=欧洲儿科胃肠病学、肝病学和营养协会(ESPGHAN)是一个专业和科学的为任何我们服务的患者和他们的家庭寻找护理标准的协会。, copyright=0, guiderPublishedTime=Wed Dec 16 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年12月,欧洲儿科胃肠病学、肝病学和营养协会(ESPGHAN)儿童IBD波尔图小组发布了关于单基因型炎症性肠病的临床基因组学诊断意见书。单基因型炎症性肠病的鉴别很重要,因其治疗不同于传统类型IBD。本文主要针对单基因型炎症性肠病的临床基因组学诊断的相关内容提供声明建议。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=1125, tagName=炎症性肠病)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=1125, guiderKeyword=炎症性肠病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2402, appHits=47, showAppHits=0, pcHits=445, showPcHits=2355, likes=0, shares=6, comments=5, approvalStatus=1, publishedTime=Wed Dec 30 00:24:21 CST 2020, publishedTimeString=2020-12-16, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Wed Dec 30 00:16:19 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 14:48:38 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 ESPGHAN意见书:单基因型炎症性肠病的临床基因组学诊.pdf)])
2020 ESPGHAN意见书:单基因型炎症性肠病的临床基因组学诊.pdf
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=976858, encodeId=193a9e6858b6, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab1c1357927, createdName=563032036, createdTime=Fri Jun 25 18:54:09 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914904, encodeId=09fb914904bc, content=好共识!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Jan 09 15:11:05 CST 2021, time=2021-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914660, encodeId=37f09146601a, content=好好学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Jan 08 16:07:47 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912631, encodeId=4354912631ca, content=好共识!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Dec 31 18:08:42 CST 2020, time=2020-12-31, status=1, ipAttribution=)]
    2021-06-25 563032036

    谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=976858, encodeId=193a9e6858b6, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab1c1357927, createdName=563032036, createdTime=Fri Jun 25 18:54:09 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914904, encodeId=09fb914904bc, content=好共识!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Jan 09 15:11:05 CST 2021, time=2021-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914660, encodeId=37f09146601a, content=好好学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Jan 08 16:07:47 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912631, encodeId=4354912631ca, content=好共识!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Dec 31 18:08:42 CST 2020, time=2020-12-31, status=1, ipAttribution=)]
    2021-01-09 jyzxjiangqin

    好共识!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=976858, encodeId=193a9e6858b6, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab1c1357927, createdName=563032036, createdTime=Fri Jun 25 18:54:09 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914904, encodeId=09fb914904bc, content=好共识!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Jan 09 15:11:05 CST 2021, time=2021-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914660, encodeId=37f09146601a, content=好好学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Jan 08 16:07:47 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912631, encodeId=4354912631ca, content=好共识!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Dec 31 18:08:42 CST 2020, time=2020-12-31, status=1, ipAttribution=)]
    2021-01-08 jyzxjiangqin

    好好学习!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=976858, encodeId=193a9e6858b6, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab1c1357927, createdName=563032036, createdTime=Fri Jun 25 18:54:09 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914904, encodeId=09fb914904bc, content=好共识!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Jan 09 15:11:05 CST 2021, time=2021-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914660, encodeId=37f09146601a, content=好好学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Jan 08 16:07:47 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912631, encodeId=4354912631ca, content=好共识!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Dec 31 18:08:42 CST 2020, time=2020-12-31, status=1, ipAttribution=)]
    2020-12-31 jyzxjiangqin

    好共识!

    0

拓展阅读

2014年加拿大炎症性肠病(IBD)与静脉血栓防治共识意见:加拿大胃肠病学会

加拿大胃肠病学协会(CAG,The Canadian Association of Gastroenterology) · 2014-03-01

2014 ESPGHAN儿童和青少年炎症性肠病诊断的波尔图标准(修订版)

欧洲儿科胃肠病学、肝病学和营养协会(ESPGHAN,European Society for Paediatric Gastroenterology, Hepatology, and Nutrition) · 2014-06-10

2014 CAG立场声明:应用巯嘌呤类药物治疗炎症性肠病

加拿大胃肠病学协会(CAG,The Canadian Association of Gastroenterology) · 2014-07-04

2015 ASGE指南:内镜检查在炎症性肠病中的作用

美国胃肠内镜学会(ASGE,American Society for Gastrointestinal Endoscopy) · 2015-03-20

2016 建立我国炎症性肠病诊治中心质量控制指标的共识

中华医学会消化病学分会炎症性肠病学组 · 2016-07-30

2017 IG-IBD临床实践指南:应用糖皮质激素和免疫抑制药物治疗炎症性肠病

意大利炎症性肠病研究组(IG-IBD,Italian Group for the Study of Inflammatory Bowel Disease) · 2017-01-25